arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

MSA Safety Incorporporated

MSA Health Care Industrial Specialties
$188.69
▲ +0.1% Today
as of Sep 4, 16:51 ET
Last 30 days +4.99% Jul 28 → Sep 04
$172.76 $178.52 $184.27 $190.02 $195.78 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$187.14
High
$190.15
Low
$187.05
Volume
$233,768
Avg Vol
$259,976
Mkt Cap
$7.3B
P/E (TTM)
46.48
Beta
—
52w High
$208.92
52w Low
$151.11
Div Yield
—
Shares Out
$39M

Recent Press Releases & News last 60 days · 25 items

Sep 3 · 20:30 PR PR Newswire
MSA Safety to Participate in Upcoming Investor Conferences
Aug 14 · 06:10 Simply Wall St.
Can MSA Safety (MSA) Justify Its Price After The Autronica Deal?
Aug 12 · 20:30 PR PR Newswire
MSA Safety Releases Latest Impact Report
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$151
$209
65% of range
Avg surprise (last 3)
+7.6%
Avg reaction (last 2)
+0.4%
50% positive
Latest IV / EM
20%
EM ±3.2% · $190 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.59$1.75$1.91$2.07$2.23 Actual $1.68Est $1.59Actual $1.93Est $1.76Actual $1.99Est $1.85Actual $2.23 Mar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$0$132M$264M$396M$528M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.23 — — — — financials
Mon May 4, 2026Mar/2026 $1.99 $1.85 +7.6% +18.4% -0.3% earnings
Mon Aug 4, 2025Jun/2025 $1.93 $1.76 +9.7% — — earnings
Tue Apr 29, 2025Mar/2025 $1.68 $1.59 +5.7% — +1.1% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$503M$464M——$474M$421M——
Cost of revenue$254M$244M—$251M$253M$228M—$225M
Gross profit$249M$220M——$221M$193M——
Operating income$112M$93M—$94M$86M$78M—$91M
Net income$86M$71M——$63M$60M——
EPS (diluted)$2.23$1.83——$1.59$1.51——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$200M$180M$165M$170M$147M$171M$165M$154M
Inventory$350M$352M$343M$355M$344M$307M$297M$352M
Total current assets$935M$892M$869M$895M$887M$823M$803M$843M
Total assets$2.60B$2.56B$2.55B$2.55B$2.55B$2.24B$2.21B$2.24B
Long-term debt$592M$605M$573M$620M$671M$469M$482M$528M
Total liabilities$1.20B$1.21B$1.19B$1.25B$1.30B$1.05B$1.06B$1.15B
Total equity$1.40B$1.36B$1.37B$1.30B$1.25B$1.19B—$1.10B

Implied volatility — last 90 days

18%32%46%60%73% Jun 07 — IV 34% · EM ±4.7%Jun 08 — IV 31% · EM ±4.1%Jun 09 — IV 31% · EM ±3.9%Jun 10 — IV 49% · EM ±5.8%Jun 11 — IV 35% · EM ±3.8%Jun 12 — IV 30% · EM ±3.1%Jun 15 — IV 38% · EM ±2.8%Jun 16 — IV 61% · EM ±3.6%Jun 17 — IV 74% · EM ±3.1%Jun 19 — IV 27% · EM ±6.0%Jun 22 — IV 26% · EM ±5.4%Jun 23 — IV 25% · EM ±5.2%Jun 24 — IV 26% · EM ±5.2%Jun 25 — IV 25% · EM ±4.9%Jun 26 — IV 25% · EM ±4.7%Jun 29 — IV 26% · EM ±4.5%Jun 30 — IV 25% · EM ±4.3%Jul 01 — IV 25% · EM ±4.1%Jul 02 — IV 24% · EM ±3.9%Jul 03 — IV 25% · EM ±3.9%Jul 06 — IV 30% · EM ±4.2%Jul 07 — IV 28% · EM ±3.7%Jul 08 — IV 34% · EM ±4.3%Jul 09 — IV 35% · EM ±4.2%Jul 10 — IV 30% · EM ±3.3%Jul 13 — IV 40% · EM ±3.3%Jul 14 — IV 48% · EM ±3.5%Jul 15 — IV 50% · EM ±2.9%Jul 16 — IV 74% · EM ±3.1%Jul 20 — IV 30% · EM ±7.0%Jul 21 — IV 29% · EM ±6.7%Jul 22 — IV 30% · EM ±6.8%Jul 23 — IV 29% · EM ±6.5%Jul 24 — IV 29% · EM ±6.5%Jul 27 — IV 30% · EM ±6.3%Jul 28 — IV 28% · EM ±5.7%Jul 29 — IV 36% · EM ±7.3%Jul 30 — IV 31% · EM ±6.1%Jul 31 — IV 25% · EM ±4.8%Aug 03 — IV 28% · EM ±5.0%Aug 04 — IV 26% · EM ±4.5%Aug 05 — IV 23% · EM ±3.8%Aug 06 — IV 22% · EM ±3.6%Aug 07 — IV 26% · EM ±4.0%Aug 10 — IV 28% · EM ±3.8%Aug 11 — IV 29% · EM ±3.8%Aug 12 — IV 27% · EM ±3.4%Aug 13 — IV 25% · EM ±2.9%Aug 14 — IV 25% · EM ±2.7%Aug 17 — IV 30% · EM ±2.5%Aug 18 — IV 36% · EM ±2.6%Aug 19 — IV 44% · EM ±2.6%Aug 20 — IV 62% · EM ±2.6%Aug 24 — IV 20% · EM ±4.1%Aug 25 — IV 20% · EM ±4.0%Aug 26 — IV 22% · EM ±4.4%Aug 27 — IV 22% · EM ±4.3%Aug 28 — IV 19% · EM ±3.6%Aug 31 — IV 21% · EM ±3.8%Sep 01 — IV 22% · EM ±3.8%Sep 02 — IV 21% · EM ±3.5%Sep 03 — IV 23% · EM ±3.8%Sep 04 — IV 20% · EM ±3.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in